Structural basis of the inhibition of cystathionine γ‐lyase from Toxoplasma gondii by propargylglycine and cysteine
Protein Science · 2023
DOI: 10.1002/pro.4619 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, 2023. Verfasst von Carmen Fernández-Rodríguez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain. Hauptthemen laut MEDLINE: Cystathionine gamma-Lyase, Toxoplasma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Economy and Competitiveness.
Abstract (Originalsprache)
Cystathionine γ‐lyase (CGL) is a PLP‐dependent enzyme that catalyzes the last step of the reverse transsulfuration route for endogenous cysteine biosynthesis. The canonical CGL‐catalyzed process consists of an α,γ‐elimination reaction that breaks down cystathionine into cysteine, α‐ketobutyrate, and ammonia. In some species, the enzyme can alternatively use cysteine as a substrate, resulting in the production of hydrogen sulfide (H 2 S). Importantly, inhibition of the enzyme and consequently of its H 2 S production activity, makes multiresistant bacteria considerably more susceptible to antibiotics. Other organisms, such as Toxoplasma gondii , the causative agent of toxoplasmosis, encode a CGL enzyme ( Tg CGL) that almost exclusively catalyzes the canonical process, with only minor reactivity to cysteine. Interestingly, the substitution of N360 by a serine (the equivalent amino acid residue in the human enzyme) at the active site changes the specificity of Tg CGL for the catalysis of cystathionine, resulting in an enzyme that can cleave both the CγS and the CβS bond of cystathionine. Based on these findings and to deepen the molecular basis underlying the enzyme‐substrate specificity, we have elucidated the crystal structures of native Tg CGL and the variant Tg CGL‐N360S from crystals grown in the presence of cystathionine, cysteine, and the inhibitor d , l ‐propargylglycine (PPG). Our structures reveal the binding mode of each molecule within the catalytic cavity and help explain the inhibitory behavior of cysteine and PPG. A specific inhibitory mechanism of Tg CGL by PPG is proposed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
- Department of Biotechnology, University of Verona, Verona, Italy.
- TEKNIKER, Basque Research and Technology Alliance (BRTA), Eibar, Gipuzkoa, Spain.
ORCID-Profile: Carolina Conter, Alessandra Astegno, Luis Alfonso Martínez-Cruz
Förderung
- Ministry of Economy and Competitiveness
Zitieren
APA
Fernández-Rodríguez, C., Conter, C., Oyenarte, I., Favretto, F., Quintana, I., Martinez-Chantar, M. L., Astegno, A., & Martínez-Cruz, L. A. (2023). Structural basis of the inhibition of cystathionine γ‐lyase from Toxoplasma gondii by propargylglycine and cysteine. Protein Science. https://doi.org/10.1002/pro.4619
Vancouver
Fernández-Rodríguez C, Conter C, Oyenarte I, Favretto F, Quintana I, Martinez-Chantar ML, et al. Structural basis of the inhibition of cystathionine γ‐lyase from Toxoplasma gondii by propargylglycine and cysteine. Protein Science. 2023. doi:10.1002/pro.4619
BibTeX
@article{FernndezRodrguez2023,
author = {Fernández-Rodríguez, Carmen and Conter, Carolina and Oyenarte, Iker and Favretto, Filippo and Quintana, Iban and Martinez-Chantar, Maria Luz and Astegno, Alessandra and Martínez-Cruz, Luis Alfonso},
title = {Structural basis of the inhibition of cystathionine γ‐lyase from Toxoplasma gondii by propargylglycine and cysteine},
journal = {Protein Science},
year = {2023},
doi = {10.1002/pro.4619}
}
EUVIMED